Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2025-12-28 @ 7:18 AM
Study NCT ID:
NCT00972335
Status:
TERMINATED
Last Update Posted:
2021-11-10
First Post:
2009-09-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-01
Start Date Type:
None
Primary Completion Date:
2014-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-07
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-02
First Submit QC Date:
None
Study First Post Date:
2009-09-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-01-05
Results First Submit QC Date:
None
Results First Post Date:
2015-06-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-08
Last Update Post Date:
2021-11-10
Last Update Post Date Type:
ACTUAL